Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:08
01/26/21
01/26
12:08
01/26/21
12:08
JNJ

Johnson & Johnson

$171.28 /

+5.27 (+3.17%)

, AXP

American Express

$118.37 /

-2.82 (-2.33%)

, VZ

Verizon

$56.67 /

-1.75 (-3.00%)

, MMM

3M

$175.21 /

+4.65 (+2.73%)

, REGN

Regeneron

$542.91 /

-6.57 (-1.20%)

, VIR

Vir Biotechnology

$57.67 /

+13.33 (+30.06%)

, BYND

Beyond Meat

$186.56 /

+27.85 (+17.55%)

, PEP

PepsiCo

$141.59 /

+1.46 (+1.04%)

, VXRT

Vaxart

$9.04 /

-1.02 (-10.14%)

, LMT

Lockheed Martin

$335.39 /

-8.495 (-2.47%)

The major averages are…

ShowHide Related Items >><<
VZ Verizon
$56.67 /

-1.75 (-3.00%)

VXRT Vaxart
$9.04 /

-1.02 (-10.14%)

VIR Vir Biotechnology
$57.67 /

+13.33 (+30.06%)

REGN Regeneron
$542.91 /

-6.57 (-1.20%)

PEP PepsiCo
$141.59 /

+1.46 (+1.04%)

MMM 3M
$175.21 /

+4.65 (+2.73%)

LMT Lockheed Martin
$335.39 /

-8.495 (-2.47%)

JNJ Johnson & Johnson
$171.28 /

+5.27 (+3.17%)

BYND Beyond Meat
$186.56 /

+27.85 (+17.55%)

AXP American Express
$118.37 /

-2.82 (-2.33%)

JNJ Johnson & Johnson
$171.28 /

+5.27 (+3.17%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
AXP American Express
$118.37 /

-2.82 (-2.33%)

01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 JPMorgan
American Express upgraded to Overweight from Underweight at JPMorgan
01/12/21 Susquehanna
American Express price target raised to $124 from $110 at Susquehanna
01/07/21 Wells Fargo
American Express selloff on WSJ story overdone, says Wells Fargo
VZ Verizon
$56.67 /

-1.75 (-3.00%)

11:24 Today MoffettNathanson
Verizon path to outperformance 'narrower' due to auction, says MoffettNathanson
06:35 Today JMP Securities
Synchrony price target raised to $43 from $36 at JMP Securities
12/02/20
Fly Intel: Top five analyst upgrades
12/02/20 MoffettNathanson
Verizon upgraded to Buy from Neutral at MoffettNathanson
MMM 3M
$175.21 /

+4.65 (+2.73%)

01/13/21 Deutsche Bank
3M named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/07/21 BofA
3M downgraded to Underperform from Neutral at BofA
10/07/20
Fly Intel: Top five analyst upgrades
10/07/20 JPMorgan
3M price target raised to $170 from $159 at JPMorgan
REGN Regeneron
$542.91 /

-6.57 (-1.20%)

09:55 Today Piper Sandler
Regeneron passive vaccine data 'compelling,' says Piper Sandler
01/25/21
Fly Intel: Top five analyst upgrades
01/25/21 BMO Capital
Regeneron upgraded to Outperform from Market Perform at BMO Capital
01/25/21 BMO Capital
Regeneron upgraded to Outperform from Market Perform at BMO Capital
VIR Vir Biotechnology
$57.67 /

+13.33 (+30.06%)

01/20/21 H.C. Wainwright
Vir Biotechnology price target raised to $125 from $100 at H.C. Wainwright
12/24/20 Baird
Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data
10/07/20 Goldman Sachs
Goldman says Lilly comments support need for multiple COVID-19 antibody makers
10/07/20 H.C. Wainwright
Vir Biotechnology price target raised to $100 from $80 at H.C. Wainwright
BYND Beyond Meat
$186.56 /

+27.85 (+17.55%)

11:09 Today William Blair
Beyond Meat will access Pepsi's systems for new products, says William Blair
10:33 Today Wells Fargo
JV doesn't change near-term trajectory for Beyond Meat, says Wells Fargo
10:05 Today JPMorgan
Beyond Meat move higher should be 'faded,' but maybe not yet, says JPMorgan
09:46 Today Oppenheimer
Beyond Meat JV with Pepsi an 'attractive longer-term driver,' says Oppenheimer
PEP PepsiCo
$141.59 /

+1.46 (+1.04%)

01/19/21 Bernstein
PepsiCo initiated with an Underperform at Bernstein
VXRT Vaxart
$9.04 /

-1.02 (-10.14%)

11/18/20 B. Riley Securities
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley Securities
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley Securities
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
08/12/20 H.C. Wainwright
Vaxart price target raised to $17 from $7 at H.C. Wainwright
LMT Lockheed Martin
$335.39 /

-8.495 (-2.47%)

01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
12/22/20 Truist
Aerojet Rocketdyne downgraded to Hold from Buy at Truist
VZ Verizon
$56.67 /

-1.75 (-3.00%)

VXRT Vaxart
$9.04 /

-1.02 (-10.14%)

VIR Vir Biotechnology
$57.67 /

+13.33 (+30.06%)

REGN Regeneron
$542.91 /

-6.57 (-1.20%)

PEP PepsiCo
$141.59 /

+1.46 (+1.04%)

MMM 3M
$175.21 /

+4.65 (+2.73%)

LMT Lockheed Martin
$335.39 /

-8.495 (-2.47%)

JNJ Johnson & Johnson
$171.28 /

+5.27 (+3.17%)

BYND Beyond Meat
$186.56 /

+27.85 (+17.55%)

AXP American Express
$118.37 /

-2.82 (-2.33%)

  • 08
    Jul
  • 27
    May
VZ Verizon
$56.67 /

-1.75 (-3.00%)

VIR Vir Biotechnology
$57.67 /

+13.33 (+30.06%)

REGN Regeneron
$542.91 /

-6.57 (-1.20%)

PEP PepsiCo
$141.59 /

+1.46 (+1.04%)

MMM 3M
$175.21 /

+4.65 (+2.73%)

LMT Lockheed Martin
$335.39 /

-8.495 (-2.47%)

JNJ Johnson & Johnson
$171.28 /

+5.27 (+3.17%)

BYND Beyond Meat
$186.56 /

+27.85 (+17.55%)

AXP American Express
$118.37 /

-2.82 (-2.33%)

VZ Verizon
$56.67 /

-1.75 (-3.00%)

VXRT Vaxart
$9.04 /

-1.02 (-10.14%)

VIR Vir Biotechnology
$57.67 /

+13.33 (+30.06%)

REGN Regeneron
$542.91 /

-6.57 (-1.20%)

PEP PepsiCo
$141.59 /

+1.46 (+1.04%)

MMM 3M
$175.21 /

+4.65 (+2.73%)

LMT Lockheed Martin
$335.39 /

-8.495 (-2.47%)

JNJ Johnson & Johnson
$171.28 /

+5.27 (+3.17%)

BYND Beyond Meat
$186.56 /

+27.85 (+17.55%)

AXP American Express
$118.37 /

-2.82 (-2.33%)

VZ Verizon
$56.67 /

-1.75 (-3.00%)

VXRT Vaxart
$9.04 /

-1.02 (-10.14%)

REGN Regeneron
$542.91 /

-6.57 (-1.20%)

PEP PepsiCo
$141.59 /

+1.46 (+1.04%)

MMM 3M
$175.21 /

+4.65 (+2.73%)

JNJ Johnson & Johnson
$171.28 /

+5.27 (+3.17%)

BYND Beyond Meat
$186.56 /

+27.85 (+17.55%)

AXP American Express
$118.37 /

-2.82 (-2.33%)

Options
Early notable gainers among liquid option names on January 26th » 09:55
01/26/21
01/26
09:55
01/26/21
09:55
GE

General Electric

$11.87 /

+0.875 (+7.96%)

, MAC

Macerich

$17.70 /

+0.47 (+2.73%)

, XL

XL Fleet

$21.18 /

+1.2801 (+6.43%)

, JNJ

Johnson & Johnson

$172.17 /

+6.16 (+3.71%)

, FOX

Fox Corp.

$31.65 /

+0.96 (+3.13%)

Notable gainers among…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XL XL Fleet
$21.18 /

+1.2801 (+6.43%)

MAC Macerich
$17.70 /

+0.47 (+2.73%)

JNJ Johnson & Johnson
$172.17 /

+6.16 (+3.71%)

GE General Electric
$11.87 /

+0.875 (+7.96%)

FOX Fox Corp.
$31.65 /

+0.96 (+3.13%)

GE General Electric
$11.87 /

+0.875 (+7.96%)

01/07/21 JPMorgan
GE shares 'de-coupled from long term fundamentals,' says JPMorgan
12/16/20 DZ Bank
General Electric upgraded to Hold from Sell at DZ Bank
12/10/20 Gordon Haskett
SEC settlement clears path for GE to issue shares, says Gordon Haskett
12/10/20 Argus
General Electric price target raised to $14 from $10 at Argus
MAC Macerich
$17.70 /

+0.47 (+2.73%)

12/21/20 JPMorgan
JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021
12/21/20 JPMorgan
Macerich downgraded to Underweight from Neutral at JPMorgan
12/15/20 Citi
Macerich downgraded to Sell from Neutral at Citi
12/14/20 KeyBanc
Macerich upgraded to Sector Weight from Underweight at KeyBanc
XL XL Fleet
$21.18 /

+1.2801 (+6.43%)

01/22/21
Fly Intel: Top five analyst initiations
01/22/21 BTIG
XL Fleet initiated with a Buy at BTIG
JNJ Johnson & Johnson
$172.17 /

+6.16 (+3.71%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
FOX Fox Corp.
$31.65 /

+0.96 (+3.13%)

10/30/20 Morgan Stanley
Morgan Stanley says ad recovery lifts outlook for Fox Corp.
07/15/20 Guggenheim
Fox Corp. price target lowered to $29 from $32 at Guggenheim
05/28/20 Jefferies
Flutter Entertainment share sale a 'confident, proactive step,' says Jefferies
04/13/20 Citi
Fox Corp. resumed with a Neutral at Citi
MAC Macerich
$17.70 /

+0.47 (+2.73%)

JNJ Johnson & Johnson
$172.17 /

+6.16 (+3.71%)

GE General Electric
$11.87 /

+0.875 (+7.96%)

FOX Fox Corp.
$31.65 /

+0.96 (+3.13%)

XL XL Fleet
$21.18 /

+1.2801 (+6.43%)

JNJ Johnson & Johnson
$172.17 /

+6.16 (+3.71%)

GE General Electric
$11.87 /

+0.875 (+7.96%)

FOX Fox Corp.
$31.65 /

+0.96 (+3.13%)

JNJ Johnson & Johnson
$172.17 /

+6.16 (+3.71%)

GE General Electric
$11.87 /

+0.875 (+7.96%)

FOX Fox Corp.
$31.65 /

+0.96 (+3.13%)

XL XL Fleet
$21.18 /

+1.2801 (+6.43%)

MAC Macerich
$17.70 /

+0.47 (+2.73%)

JNJ Johnson & Johnson
$172.17 /

+6.16 (+3.71%)

GE General Electric
$11.87 /

+0.875 (+7.96%)

FOX Fox Corp.
$31.65 /

+0.96 (+3.13%)

Hot Stocks
Johnson & Johnson says 'comfortable' meeting COVID-19 vaccine demand  09:30
01/26/21
01/26
09:30
01/26/21
09:30
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Hot Stocks
Johnson & Johnson sees no biosimilar entrants in Pharmaceutical segment in FY21  09:21
01/26/21
01/26
09:21
01/26/21
09:21
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Conference/Events
DIA to hold a virtual conference » 09:19
01/26/21
01/26
09:19
01/26/21
09:19
ABBV

AbbVie

$110.26 /

-0.6 (-0.54%)

, ALXN

Alexion

$161.30 /

+1.55 (+0.97%)

, AZN

AstraZeneca

$54.02 /

+0.76 (+1.43%)

, BIIB

Biogen

$275.38 /

+6.16 (+2.29%)

, BMY

Bristol-Myers

$64.82 /

+0.26 (+0.40%)

, ESALY

Eisai

$0.00 /

+ (+0.00%)

, HALO

Halozyme

$48.78 /

-0.73 (-1.47%)

, IQV

Iqvia

$182.87 /

-3.04 (-1.64%)

, LLY

Eli Lilly

$212.52 /

+6.22 (+3.02%)

, MSFT

Microsoft

$229.34 /

+3.45 (+1.53%)

Pharmacovigilance &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

01/06/21 RBC Capital
AbbVie named one of top stocks to own in 2021 by RBC Capital
12/17/20 Stifel
Outcome in Evolus IP case 'better than most investors expected,' says Stifel
12/16/20 SVB Leerink
AbbVie price target raised to $128 from $119 at SVB Leerink
12/15/20 Mizuho
AbbVie price target raised to $117 from $111 at Mizuho
ALXN Alexion
$161.30 /

+1.55 (+0.97%)

01/08/21 Raymond James
Alexion downgraded to Market Perform from Outperform at Raymond James
12/16/20 Truist
Alexion downgraded to Hold from Buy at Truist
12/15/20 Truist
Argenx price target raised to $350 from $275 at Truist
12/14/20 Citi
Alexion downgraded to Neutral from Buy at Citi
AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

01/22/21 Barclays
AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays
01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
01/15/21 Berenberg
AstraZeneca price target lowered to 10,000 GBp from 10,500 GBp at Berenberg
01/15/21
Fly Intel: Top five analyst initiations
BIIB Biogen
$275.38 /

+6.16 (+2.29%)

01/14/21 Truist
Truist says FDA wouldn't be discussing label if not going to approve aducanumab
01/11/21 Goldman Sachs
Eli Lilly's Alzheimer's trial data a 'positive surprise,' says Goldman Sachs
12/04/20 Mizuho
Sage Therapeutics upgraded to Buy from Neutral at Mizuho
12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
01/20/21 Citi
Citi opens 'negative Catalyst Watch' on Bristol-Myers
12/15/20 Goldman Sachs
Bristol-Myers upgraded to Conviction Buy from Buy at Goldman Sachs
12/09/20 Mizuho
Pentwater seeks to replace Bristol-Myers Squibb CVR trustee, says Mizuho
ESALY Eisai
$0.00 /

+ (+0.00%)

11/05/20 Jefferies
Eisai upgraded to Buy from Hold at Jefferies
09/08/20 Jefferies
Eisai downgraded to Hold from Buy at Jefferies
HALO Halozyme
$48.78 /

-0.73 (-1.47%)

01/25/21 BMO Capital
Halozyme price target raised to $65 from $56 at BMO Capital
01/21/21 Benchmark
Halozyme price target raised to $59 from $46 at Benchmark
01/14/21 Piper Sandler
Halozyme price target raised to $50 from $42 at Piper Sandler
01/11/21 Benchmark
Phesgo EU approval/Horizon deal fuel Halozyme increased guidance, says Benchmark
IQV Iqvia
$182.87 /

-3.04 (-1.64%)

12/18/20 Mizuho
Iqvia price target raised to $200 from $190 at Mizuho
10/22/20 Deutsche Bank
Iqvia price target raised to $196 from $180 at Deutsche Bank
10/21/20 UBS
Iqvia price target raised to $224 from $204 at UBS
10/21/20 Morgan Stanley
Iqvia price target raised to $195 from $182 at Morgan Stanley
LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

01/20/21 Citi
Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data
01/19/21 Roth Capital
Merus price target raised to $32 from $19 at Roth Capital
01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 Mizuho
Eli Lilly upgraded to Buy from Neutral at Mizuho
MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

01/25/21 Morgan Stanley
Morgan Stanley says market closer to recognizing Alphabet sum-of-the-parts value
01/25/21 DA Davidson
Box downgraded to Neutral from Buy at DA Davidson
01/22/21 RBC Capital
Varonis price target raised to $200 from $165 at RBC Capital
MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

IQV Iqvia
$182.87 /

-3.04 (-1.64%)

HALO Halozyme
$48.78 /

-0.73 (-1.47%)

ESALY Eisai
$0.00 /

+ (+0.00%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

MSFT Microsoft
$229.34 /

+3.45 (+1.53%)

LLY Eli Lilly
$212.52 /

+6.22 (+3.02%)

BMY Bristol-Myers
$64.82 /

+0.26 (+0.40%)

BIIB Biogen
$275.38 /

+6.16 (+2.29%)

AZN AstraZeneca
$54.02 /

+0.76 (+1.43%)

ALXN Alexion
$161.30 /

+1.55 (+0.97%)

ABBV AbbVie
$110.26 /

-0.6 (-0.54%)

Hot Stocks
Johnson & Johnson sees FY21 adjusted pre-tax operating margin up ~200 bps  09:16
01/26/21
01/26
09:16
01/26/21
09:16
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Hot Stocks
Johnson & Johnson says Phase 3 COVID-19 vaccine study results due next week » 09:06
01/26/21
01/26
09:06
01/26/21
09:06
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

Says Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

On The Fly
Fly Intel: Pre-market Movers » 09:03
01/26/21
01/26
09:03
01/26/21
09:03
ICLK

iClick Interactive Asia

$13.92 /

+0.555 (+4.15%)

, ETSY

Etsy

$208.86 /

-4.58 (-2.15%)

, JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

, RTX

Raytheon Technologies

$66.30 /

-1.32 (-1.95%)

, MMM

3M

$170.50 /

+1.47 (+0.87%)

, ADM

Archer Daniels

$53.10 /

+0.24 (+0.45%)

, DHI

D.R. Horton

$79.00 /

+1.24 (+1.59%)

, PII

Polaris

$119.51 /

+1 (+0.84%)

, VZ

Verizon

$58.42 /

+0.95 (+1.65%)

, AXP

American Express

$121.19 /

-4.92 (-3.90%)

, LMT

Lockheed Martin

$343.49 /

+2.81 (+0.82%)

, IZEA

Izea

$6.96 /

+2.27 (+48.40%)

, KRMD

Koru Medical

$5.13 /

-0.06 (-1.16%)

, GE

General Electric

$11.00 /

-0.125 (-1.12%)

Check out this morning's…

ShowHide Related Items >><<
VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

PII Polaris
$119.51 /

+1 (+0.84%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

IZEA Izea
$6.96 /

+2.27 (+48.40%)

ICLK iClick Interactive Asia
$13.92 /

+0.555 (+4.15%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

ETSY Etsy
$208.86 /

-4.58 (-2.15%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

ICLK iClick Interactive Asia
$13.92 /

+0.555 (+4.15%)

08:38 Today Benchmark
iClick, Baozun partnership a strategic positive for both, says Benchmark
01/20/21 Alliance Global Partners
iClick Interactive Asia price target raised to $18 from $12 at Alliance Global
09/29/20 China Renaissance
iClick Interactive Asia initiated with a Buy at China Renaissance
09/10/20 Alliance Global Partners
iClick Interactive Asia price target raised to $12 from $10 at Alliance Global Partners
ETSY Etsy
$208.86 /

-4.58 (-2.15%)

07:59 Today Jefferies
Etsy price target raised to $245 from $205 at Jefferies
01/25/21 Loop Capital
Etsy price target raised to $240 from $210 at Loop Capital
01/22/21 KeyBanc
Etsy price target raised to $235 from $180 at KeyBanc
01/14/21 Roth Capital
Etsy price target raised to $235 from $165 at Roth Capital
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

12/21/20 Canaccord
Boeing not in position to challenge Aerojet bid, says Canaccord
12/21/20 RBC Capital
Aerojet Rocketdyne price target raised to $56 from $51 at RBC Capital
12/17/20 DZ Bank
Raytheon Technologies upgraded to Buy from Hold at DZ Bank
12/15/20 JPMorgan
Raytheon Technologies price target raised to $85 from $79 at JPMorgan
MMM 3M
$170.50 /

+1.47 (+0.87%)

01/13/21 Deutsche Bank
3M named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/07/21 BofA
3M downgraded to Underperform from Neutral at BofA
10/07/20
Fly Intel: Top five analyst upgrades
10/07/20 JPMorgan
3M price target raised to $170 from $159 at JPMorgan
ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

01/20/21 Credit Suisse
Archer Daniels price target raised to $54 from $46 at Credit Suisse
01/11/21 BMO Capital
Archer Daniels downgraded to Market Perform from Outperform at BMO Capital
12/21/20 Barclays
Bunge price target raised to $70 from $65 at Barclays
11/09/20 Barclays
Archer Daniels price target raised to $55 from $52 at Barclays
DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

01/21/21 Janney Montgomery Scott
Meritage Homes initiated with a Neutral at Janney Montgomery Scott
01/21/21 Janney Montgomery Scott
D.R. Horton initiated with a Neutral at Janney Montgomery Scott
01/08/21 RBC Capital
D.R. Horton upgraded to Outperform from Sector Perform at RBC Capital
01/08/21 RBC Capital
D.R. Horton upgraded to Outperform from Sector Perform at RBC Capital
PII Polaris
$119.51 /

+1 (+0.84%)

01/20/21
Fly Intel: Top five analyst initiations
01/20/21 Morgan Stanley
Morgan Stanley starts Polaris at Overweight with $140 price target
01/20/21 BMO Capital
Polaris upgraded to Outperform from Market Perform at BMO Capital
01/19/21 Morgan Stanley
Polaris initiated with an Overweight at Morgan Stanley
VZ Verizon
$58.42 /

+0.95 (+1.65%)

06:35 Today JMP Securities
Synchrony price target raised to $43 from $36 at JMP Securities
12/02/20
Fly Intel: Top five analyst upgrades
12/02/20 MoffettNathanson
Verizon upgraded to Buy from Neutral at MoffettNathanson
12/02/20 MoffettNathanson
Verizon upgraded to Buy from Neutral at MoffettNathanson
AXP American Express
$121.19 /

-4.92 (-3.90%)

01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 JPMorgan
American Express upgraded to Overweight from Underweight at JPMorgan
01/12/21 Susquehanna
American Express price target raised to $124 from $110 at Susquehanna
01/07/21 Wells Fargo
American Express selloff on WSJ story overdone, says Wells Fargo
LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
12/22/20 Truist
Aerojet Rocketdyne downgraded to Hold from Buy at Truist
IZEA Izea
$6.96 /

+2.27 (+48.40%)

06:59 Today Ladenburg
Ladenburg downgrades Izea to Sell on 'excessive' valuation
06:42 Today Ladenburg
Izea downgraded to Sell from Neutral at Ladenburg
11/13/20 Ladenburg
Izea downgraded to Neutral on 'muted' bookings growth at Ladenburg
11/13/20 Ladenburg
Izea downgraded to Neutral from Buy at Ladenburg
KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

07:55 Today Canaccord
Canaccord downgrades Koru Medical, sees sluggish trends persisting
05:33 Today Canaccord
Koru Medical downgraded to Hold from Buy at Canaccord
01/25/21 Piper Sandler
Koru Medical downgraded to Neutral from Overweight at Piper Sandler
11/04/20 Piper Sandler
Koru Medical earnings selloff a buying opportunity, says Piper Sandler
GE General Electric
$11.00 /

-0.125 (-1.12%)

01/07/21 JPMorgan
GE shares 'de-coupled from long term fundamentals,' says JPMorgan
12/16/20 DZ Bank
General Electric upgraded to Hold from Sell at DZ Bank
12/10/20 Gordon Haskett
SEC settlement clears path for GE to issue shares, says Gordon Haskett
12/10/20 Argus
General Electric price target raised to $14 from $10 at Argus
VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

PII Polaris
$119.51 /

+1 (+0.84%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

ICLK iClick Interactive Asia
$13.92 /

+0.555 (+4.15%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

ETSY Etsy
$208.86 /

-4.58 (-2.15%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

  • 03
    Sep
  • 19
    Jun
VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

ETSY Etsy
$208.86 /

-4.58 (-2.15%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

PII Polaris
$119.51 /

+1 (+0.84%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

LMT Lockheed Martin
$343.49 /

+2.81 (+0.82%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

ICLK iClick Interactive Asia
$13.92 /

+0.555 (+4.15%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

ETSY Etsy
$208.86 /

-4.58 (-2.15%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

VZ Verizon
$58.42 /

+0.95 (+1.65%)

RTX Raytheon Technologies
$66.30 /

-1.32 (-1.95%)

MMM 3M
$170.50 /

+1.47 (+0.87%)

KRMD Koru Medical
$5.13 /

-0.06 (-1.16%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GE General Electric
$11.00 /

-0.125 (-1.12%)

ETSY Etsy
$208.86 /

-4.58 (-2.15%)

DHI D.R. Horton
$79.00 /

+1.24 (+1.59%)

AXP American Express
$121.19 /

-4.92 (-3.90%)

ADM Archer Daniels
$53.10 /

+0.24 (+0.45%)

Earnings
Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 » 06:50
01/26/21
01/26
06:50
01/26/21
06:50
JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

Consensus $8.99. Sees…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Hot Stocks
Genmab reports $4.109B in worldwide net trade sales of Darzalex in 2020 » 06:49
01/26/21
01/26
06:49
01/26/21
06:49
GMAB

Genmab

$42.68 /

-0.41 (-0.95%)

, JNJ

Johnson & Johnson

$165.91 /

+2.23 (+1.36%)

Genmab (GMAB) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

GMAB Genmab
$42.68 /

-0.41 (-0.95%)

GMAB Genmab
$42.68 /

-0.41 (-0.95%)

01/25/21 DNB Markets
Genmab downgraded to Sell from Hold at DNB Markets
01/19/21 Morgan Stanley
Genmab downgraded to Equal Weight on valuation at Morgan Stanley
01/19/21 Morgan Stanley
Genmab downgraded to Equal Weight from Overweight at Morgan Stanley
01/15/21 H.C. Wainwright
Genmab price target raised to $49 from $44 at H.C. Wainwright
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

01/15/21 B. Riley Securities
Arcturus Therapeutics downgraded to Neutral from Buy at B. Riley Securities
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
12/29/20 Piper Sandler
Piper still believes in Arcturus vaccine after 'underwhelming' immunogenicity
JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

JNJ Johnson & Johnson
$165.91 /

+2.23 (+1.36%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.